Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Aventis--World's No. 1 Drugmaker -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (15)	4/10/2000 3:45:00 PM
From: BillQ	Respond to of 22

Thanks Mike.

To: Mike McFarland who wrote (15)	5/26/2000 7:30:00 PM
From: Mike McFarland	Read Replies (1) \| Respond to of 22

Huge pharma has had a nice run up these past couple months, and Aventis is no exception. My guess is that we are going to see the Mercks and Pfizers of the world start to leak at about the same time that the biotechs start moving back up. Might not be next week, but I think this scenario becomes increasingly likely into the summer. I was going to try and support that statement with something about rising interest rates not affecting biotech, and elections and pharma, but instead, I'll just call it what it is--a guess, and invite anybody to add their two cents. Will the safety of big pharma in the big tech correction last--or is this just a trading range thing and the move up is mostly done? Sure wish I'd stayed in a few of those pharmas I'd looked at back in March (sgp and ave)--if you start replacing fifty percent losses (in biotech) with thirty percent gains in pharma, ah what might have been! But it does not seem like the time to capitulate--getting out of phase with the bio/pharma oscillation just as things, I hope, reverse yet again, could be pretty hazardous. Staying the course, but a damn rough ride.